newsletter

Trump Blocks Foreign Doctors, Then Blinks: Inside America’s Residency Crisis American medicine relies on a workforce it does not always make it easy to join. A quarter of its doctors are international medical graduates (IMGs), rural areas rely on their presence heavily, and the AAMC estimates a shortfall of up to 86,000 physicians by 2036. Against that backdrop, 2026 has been a year of whiplash for foreign-trained doctors: a sweeping freeze, a quiet reversal, and obstacles that remain in place. A Freeze, Then a Carve-Out This winter, USCIS began freezing processing of immigration benefits, including work authorization extensions, green card applications and naturalization, for people already in the U.S. from 39 countries. The consequences reached the bedside quickly. Hospitals began placing affected physicians on administrative leave as their work authorization expired. Homeland Security defended the freeze, believing visa holders from those countries had not been properly vetted. Medical organizations pushed back. On April 8, more than 20 of them jointly urged the administration to act. The reversal came in May, without a formal announcement: USCIS updated its website to indicate that physicians are no longer subject to the processing hold. Reason magazine called the exemption a positive development, but a narrow solution to a bigger problem. The Barriers That Remain Two structural problems persist. The first is cost. Hospitals are finding it hard to sponsor international physicians because of the $100,000 H-1B fee introduced last fall. For a community hospital or non-profit teaching program operating on thin margins, a six-figure fee per sponsored physician can decide whether a candidate is viable at all. The second is the J-1 waiver pipeline. Graduating residents on J-1 visas can transition to work status by committing to several years in an underserved area, a process that has historically taken weeks. Delays in processing waiver applications for the HHS-run program could affect hundreds of foreign doctors about to finish training. A delay of months for a physician whose training contract has ended can mean losing a position entirely, and the patients who were expecting that doctor lose too. What the Match Data Show The numbers from the 2026 Main Residency Match, as cited in the source material for this piece, point the same way. Non-U.S. IMGs matched at 54.4%, a five-year low, while U.S. IMGs matched at 67.9%, a five-year high. Policy uncertainty is not the only possible driver, since match rates reflect applicant pools, program preferences and specialty mix. Still, a widening gap between candidates who need sponsorship and those who do not is what one would expect when sponsorship becomes costlier and less predictable. A Parallel Debate: Defining the “Qualified” Physician The same underlying question, who counts as qualified and what that means for patients, is at the center of a separate dispute over medical school admissions. A Newsweek analysis examines the Justice Department’s case against UCLA’s medical school. The DOJ’s findings letter says UCLA admitted Black and Hispanic students in 2023 with a median MCAT score of 507, the 68th percentile, compared with 514, the 88th percentile, for admitted Asian and white students. UCLA says its admissions process is based on merit and complies with state and federal law. The piece is an opinion-style analysis, and readers should treat it as such. It concedes that if race was used impermissibly after the Supreme Court’s affirmative action ruling, the school faces a serious legal problem. It then argues that test scores capture only part of what makes a physician effective, and points to research on patient-doctor concordance. In an Oakland study published in the American Economic Review, Black men randomly assigned to Black doctors were much more likely to choose preventive services, particularly invasive ones. The evidence is not settled, and the article says so. Some findings are observational, some measure satisfaction rather than survival, and a review protocol noted two decades of concordance research had produced contradictory results. Critics have also argued that controlling for very low birth weight weakened or eliminated the effect in a widely cited newborn-mortality study. The fair reading is that the research justifies continued study, not a basis for race-conscious admissions, and that test scores alone do not settle who will practice well. Those two conclusions are compatible. For IMGs, the connection is indirect but real. Foreign-trained physicians are valued partly because they staff places and populations that U.S. graduates often do not reach. That is a form of merit that no examination score captures, and one that policy choices can either preserve or erode. What to Watch Three developments will shape the next application cycle: whether the physician exemption holds, whether the H-1B fee is narrowed for healthcare employers, and whether HHS clears its waiver backlog. For applicants, the practical lesson is to plan around policy volatility, since visa pathways can change faster than training timelines

America’s Hospitals Have Been Sold When Hospitals Stopped Being Hospitals: Inside the Corporate Takeover of American Healthcare Somewhere in America right now, a hospital is being bought. Not by a health system, not by a city, not by doctors who trained inside its walls — but by a private equity fund headquartered a thousand miles away, its interest measured not in patients saved but in returns generated over a three-to-seven-year hold period. This is not a hypothetical. This is the architecture of American medicine in 2026. The Numbers Behind the Quiet Invasion The scale is staggering once you see it clearly. Roughly 447 U.S. hospitals now sit inside private equity portfolios — 8% of all private hospitals, 22% of every for-profit facility in the country. A quarter of them are the only hospital for miles in rural communities, where a boardroom decision made in Manhattan or Miami can, without warning, become the difference between an ambulance ride of ten minutes and one of ninety. It didn’t happen overnight. It happened quietly, deal by deal, while patients kept walking through the same front doors under the same familiar signage — unaware that the entity now deciding staffing levels, equipment budgets, and which services stay open had never treated a single patient in its life. The Collapse That Exposed Everything If this transformation had a single, cinematic breaking point, it was Steward Health Care — once the largest private for-profit hospital system in America. Private equity acquired it in 2010, extracted value from it, and sold it off in 2020. By 2024, it was gone: bankrupt, its more-than-30 hospitals across eight states thrown into chaos, patients collapsing in overwhelmed emergency rooms while, according to widely reported headlines, its CEO’s $40 million yacht sat anchored in the Galápagos Islands. It was the kind of image that turns an abstract financial structure into a national scandal. What the Evidence Actually Shows Strip away the drama and the science tells the same story with cold precision. A bipartisan U.S. Senate Budget Committee investigation combed through more than a million internal documents and reached an unambiguous conclusion: private equity firms extracted enormous profits from hospitals while loading them with debt, and patient care and safety measurably declined as a result. The clinical data is just as damning. A systematic review spanning studies from 2010 to 2026 found that private-equity-owned hospitals showed consistently higher mortality rates, more surgical complications, elevated failure-to-rescue rates, and more hospital-acquired infections than their non-PE counterparts. This isn’t anecdote. It’s peer-reviewed pattern. And the financial mechanics explain why: private-equity-backed companies represent just 7% of U.S. GDP, yet accounted for 21% of all healthcare bankruptcies in 2024 — including seven of that year’s eight largest collapses. Roll-up acquisitions consolidate market power and drive up prices for insurers, patients, and Medicare alike. Management fees, sometimes charged even when no service is rendered, siphon cash out of hospital operations and into investor pockets. The Reckoning Ahead What began as a financial footnote has become a full-blown public health question. Momentum is building on Capitol Hill — bipartisan, rare in this era — alongside new position papers from medical bodies like the American College of Physicians demanding transparency about who actually owns America’s hospitals and tighter guardrails on debt-financed acquisitions. The sign outside your local hospital may not have changed. But behind it, a different kind of institution has been quietly taking shape — one built less around the Hippocratic oath and more around the exit strategy.

What Separates a Competitive IMG Application From the Rest Determining whether your profile as an International Medical Graduate (IMG) is competitive requires an honest, data-driven comparison between your personal metrics and current benchmarks published by the National Resident Matching Program (NRMP), alongside a realistic assessment of your clinical exposure and visa timeline. Competitiveness is rarely determined by a single factor; rather, it emerges from the interaction of academic performance, clinical experience, documentation, and external circumstances such as immigration status. Core Academic and Clinical Metrics USMLE Step 2 CK Score. This remains one of the most heavily weighted screening criteria used by residency programs. A score above 245 is generally regarded as competitive for primary care specialties, while more selective or procedure-based fields typically require scores exceeding 250. Scores below 225 place applicants at meaningfully higher risk of being filtered out by automated screening systems before a human reviewer ever sees the application. Year of Graduation (YOG). Program directors tend to favor recency. Graduating within three to five years of application keeps a candidate eligible for the majority of programs. Applicants further removed from graduation are not automatically disqualified, but they generally need to compensate with demonstrable, recent U.S. clinical activity or research productivity to reassure programs of their current clinical readiness. U.S. Clinical Experience (USCE). Roughly eight to sixteen weeks of hands-on rotations or externships in U.S. clinical settings is considered a reasonable threshold. This experience signals familiarity with U.S. documentation standards, interprofessional communication norms, and the structure of American healthcare delivery — all of which are difficult to assess from international training alone. Letters of Recommendation (LoRs). Three strong, U.S.-based letters from physicians who supervised the applicant directly and can speak specifically to clinical performance tend to carry more weight than a larger number of generic or international letters. Depth and specificity of endorsement matter more than volume. Contextual Factors That Shape Competitiveness Beyond these core metrics, several structural factors influence how an application is likely to be received. Visa Status. Immigration requirements have a measurable effect on match outcomes. IMGs who require J-1 or H-1B visa sponsorship have historically matched at a lower rate — approximately 54 percent — compared to U.S. permanent residents or citizens, who match at rates closer to 68–70 percent. This disparity reflects the administrative and financial burden that sponsorship places on programs, not necessarily a reflection of clinical ability, and it should factor into how broadly and strategically an applicant targets programs. Specialty Choice. Not all specialties present equal opportunity for IMGs. Primary care fields such as Internal Medicine and Family Medicine, and to a lesser extent Pediatrics, have historically been more accessible, largely because these specialties offer a higher number of positions and a longer track record of successfully integrating IMGs into their programs. Highly competitive or procedural specialties, including surgical subspecialties and dermatology, remain statistically more difficult for IMGs to enter, regardless of otherwise strong metrics. Program Targeting. Even a strong applicant can underperform in the Match if their program list is poorly targeted. Tools such as FREIDA and Residency Explorer allow applicants to filter programs by historical IMG interview and match rates, helping to align individual metrics with programs that have demonstrated openness to IMG candidates. Putting It Together A truly competitive IMG profile is best understood as a portfolio rather than a checklist. A borderline Step 2 CK score, for instance, may be offset by strong, specific U.S.-based letters and substantial recent clinical experience. Conversely, an excellent board score cannot fully compensate for a long gap since graduation with no demonstrable recent clinical activity, or for a specialty choice that is structurally unfavorable to IMGs. The most effective way to gauge competitiveness, therefore, is to benchmark each of these metrics individually against current NRMP outcome data for your intended specialty, identify which elements of your profile fall below target thresholds, and take deliberate steps — additional USCE, more targeted letter requests, or reconsideration of specialty and program list — to strengthen those specific gaps well in advance of application season.